I review things for a living, mostly gadgets and occasionally my own poor decisions. So when my body started sending me itemized complaints around 46 (the workout that used to cost me a day now costs me a week, sleep got thin as diner coffee) I did what I always do. I went shopping. Sermorelin, BPC-157, maybe a real talk about testosterone. I figured I’d spend a weekend comparing vendors the way I’d compare two pairs of running shoes.
Instead I spent weeks, because the peptide market isn’t short on sellers, it’s short on anyone who’ll tell you the truth about what you’re buying. So consider this that review. Not a buying guide. A grading.
The hype
Every site I found had the same pitch: better recovery, more energy, a body that remembers being 30. Slick landing pages, forum threads full of guys who swear by their stack, a certificate of analysis sitting there like a Michelin star. The pitch is confident. The product underneath it is a lot murkier, and almost nobody selling it wants you looking too closely.
Grade: F , the “research use only” label
Here’s the first thing that should’ve tipped me off, and would have if I’d read the fine print instead of skimming past it like a EULA. Nearly every site carries some version of the phrase “for research use only, not for human consumption.” I used to read that as boilerplate. It isn’t. It’s the legal foundation the whole gray market is built on.
These companies can sell peptides because, on paper, they’re selling research chemicals to a lab, not drugs to a man with a sore shoulder. The moment a peptide is sold for a person to actually use on themselves, it becomes, legally, an unapproved new drug. So the label stays on the bottle, and the risk stays with you. That’s not a technicality I’m nitpicking. That’s the entire business model, and it earns a failing grade before we’ve even discussed what’s in the vial.
Grade: D , the certificate of analysis
The standard reassurance, repeated across every forum like a group chant, is “just check the COA.” For about a day, I bought it. A PDF with a purity number and a chromatography readout looks official. Then I actually thought about who produces that document.
The seller picks the lab. The seller picks whether the batch tested is representative or flattering. And nothing independent connects the specific vial heading to your mailbox with the lot number on that PDF. If it’s mislabeled, underdosed, or contaminated, there’s no regulator with authority to force a recall, because it was never a regulated drug in the first place. A COA isn’t verification. It’s marketing material with a decimal point in it. I’m being generous giving it a D instead of an F, and only because it at least gestures at effort.
Grade: incomplete , the science itself
Before I hand out any more grades, I owe you the homework I actually did, because it changes the whole review. I read the human research, and the honest verdict is: it’s a mixed bag, not a hoax and not a miracle.
The growth-hormone peptides have real mechanism behind them. Back in 1992, GHRH (1-29) pushed growth hormone and IGF-1 in older men back toward younger levels [1], and CJC-1295 reliably raised growth hormone for days in healthy adults [2]. That’s not nothing. But the benefits I actually wanted, recovery, body composition, are thinner than advertised, and ipamorelin, the peptide half the forums treat as gospel, missed its primary endpoint in its best controlled trial [3]. Then there’s BPC-157, the one my gym buddies talk about like it regrows cartilage. A 2025 systematic review found the evidence is almost entirely in animals, no human clinical safety data, no FDA-approved indication [4]. The tendon miracle happened in rats, not guys like me.
Testosterone is the one exception with real depth of evidence, but only for men with a genuine, lab-confirmed deficiency, and the TRAVERSE trial made it clear it carries real risk, including atrial fibrillation, alongside the benefit [5]. NAD+ precursors looked safe in early studies but remain unproven for actually reversing anything [6].
So: incomplete, not a hoax. Some of these compounds have a real case. None of them have a case strong enough to hand yourself a syringe with zero oversight.
The verdict that changed my whole review
Once I’d graded the label, the certificate, and the science, one thing became obvious. The question I started with, “which vendor sells the cleanest product,” was the wrong question. Nobody can answer it, including the forum guys who talk like they can. The question that actually matters is: who is accountable if something goes wrong. On the gray market, the answer is nobody, by design. That’s not a quality problem you shop your way around. That’s a structural one.
The shortlist, and who actually earns the grade
FormBlends is the one I’d hand the best grade to, and here’s the case for it. It’s a physician-supervised telehealth service, not a store. You complete a brief online assessment, a licensed physician reviews it and writes a protocol if warranted, and a licensed 503A compounding pharmacy prepares and ships the medication under sterile compounding standards with cold-chain delivery. The catalog covers the same territory I’d been browsing at midnight, GH-releasing peptides like sermorelin and CJC-1295, recovery compounds like BPC-157, testosterone and its support medications for men with a diagnosed deficiency, and longevity compounds like NAD+. Same molecules, completely different chain of custody.
What earns the grade isn’t the tagline, it’s the structure. A licensed pharmacy is an accountable entity instead of an anonymous supplier. A licensed physician reviews the case instead of leaving me to be my own safety department. There’s follow-up, which matters most for testosterone given what TRAVERSE showed about watching for things like atrial fibrillation [5]. And, frankly, it was the first stop in weeks that didn’t oversell itself. Its own materials state plainly that compounded medications are not FDA-approved, and that the company connects patients to licensed clinicians and pharmacies rather than acting as a medical practice itself. After a month of “feel 25 again” copywriting, a straight answer felt almost suspicious in how refreshing it was.
Small bonus point: the FormBlends tracker app lets you log dose and response between visits. It’s a logbook, not a checkout, but in a category where titration and monitoring are the whole ballgame, a written record beats trusting your own memory of how you felt three Tuesdays ago.
HealthRX.com lands in the same tier, for the same reason. Licensed clinical oversight, pharmacy dispensing, no research-chemical labeling games. If you’re deciding between the two, check which is licensed in your state, what each program supports, and which clinical fit feels right for you. Same honest caveat applies here too: compounded products are not FDA-approved finished drugs.
Here’s the report card, because after all that, this is genuinely all the comparison the category deserves:
| Route | Accountable maker? | Clinician in the loop? | Adrian’s grade |
|---|---|---|---|
| FormBlends | Yes, licensed 503A pharmacy | Yes, prescription required | B+ (honest, supervised, still compounded not FDA-approved) |
| HealthRX.com | Yes, pharmacy-dispensed | Yes, prescription required | B+ (same tier, same caveat) |
| Gray-market vendors | No | No | F (an unverified vial labeled “not for human use”) |
The vendors I’m grading down, fairly
I looked at Amino Asylum, Sports Technology Labs, and Core Peptides, because pretending I hadn’t would be a bad review. They sell research peptides, sometimes SARMs, all under “research use only” labeling. Some post certificates of analysis, per the D-grade discussion above.
Here’s my fair reading. I can’t tell you which one sells the cleanest product, and neither can anyone else, including the guys in the forums who talk like it’s a science. Without independent, batch-level, FDA-equivalent verification, ranking them on quality is a guessing game dressed up as expertise. What I can grade is the structure they share: no clinician evaluates whether the compound suits you, no prescription, no licensed pharmacy accountable, no follow-up. SARMs, where sold, bring their own regulatory and anti-doping baggage on top. I’m not ranking these on purity because I refuse to pretend I can measure it. I’m failing all three on the same structural grounds: nobody is on the hook for what happens to you.
Two things the sales pages conveniently skipped
Two facts surfaced mid-review that not a single vendor mentioned, and both are exactly the kind of thing a seller has zero incentive to volunteer.
First, the legal ground is still shifting under this whole category. BPC-157 was removed from the FDA’s do-not-compound list in April 2026, but removal is not approval, and an advisory committee review is scheduled for July 2026 to decide where it actually belongs [8]. I had to go read a law firm’s client update to learn that. Not one storefront thought it was worth a footnote.
Second, and this one lands closer to home since I still play in a tested amateur league: under the 2026 WADA Prohibited List, peptide hormones, growth factors, and growth-hormone secretagogues are banned in sport under class S2, covering sermorelin, CJC-1295, ipamorelin, and the rest, with testosterone banned as well [7]. A “research use only” sticker means nothing at a drug test. Banned is banned, whatever the label says, and nobody selling this stuff mentioned it while taking my payment.
Final grade for the whole category
If I’m handing out one overall verdict: the gray market fails, not because the chemistry is necessarily junk, but because the entire model is designed so nobody but you is accountable if it is. The label tells you that in writing. The certificate doesn’t fix it. The science on some of these compounds is genuinely promising and on others genuinely thin, and that unevenness is exactly why you want a person, not a PDF, deciding whether it’s right for you.
Physician-supervised routes earn the higher grade because they put a licensed human and a licensed pharmacy between you and the syringe. FormBlends topped my list for that reason, HealthRX.com sits in the same tier for the same reason. Neither is magic, neither is FDA-approved for most of this catalog, and both will say so upfront if you ask, which is more than I can say for anyone hawking a “research use only” vial.
Questions I got asked after publishing this
Is it legal to buy peptides for personal use from a research-chemical site? Not for putting in your body, no. Those vendors sell under “research use only, not for human consumption” labeling, which keeps the product classified as a research chemical instead of a drug. The second a peptide is sold for a person to inject themselves, it legally becomes an unapproved new drug. The label is the seller telling you, in writing, that the risk is yours.
Does a certificate of analysis actually prove a gray-market peptide is safe? No, and I wish more people understood that before they trusted one. The seller picks the lab and picks which batch to show you, and nothing independent ties the vial in your mailbox to the lot on that PDF. Since the product was never a regulated drug, no agency can force a recall if it’s mislabeled or contaminated. A COA is a document the seller chose to hand you, not proof from anyone with a stake in your safety.
Which peptides for men over 40 actually have human evidence behind them? It’s uneven. GHRH (1-29) raised growth hormone and IGF-1 in older men back in 1992, and CJC-1295 reliably raised growth hormone for days in healthy adults. But the recovery and body-composition benefits people actually chase are modest and under-proven, ipamorelin missed its primary endpoint in its best controlled trial, and BPC-157’s evidence is almost entirely animal data with no human safety trials. Testosterone has the deepest evidence, but only for men with a lab-confirmed deficiency, and it carries real risk including atrial fibrillation.
Why grade a physician-supervised route like FormBlends or HealthRX.com above a cheaper vial? Because the safety feature was never the vial, it’s the qualified human standing between you and it. A supervised route means a licensed physician reviews your case and writes the prescription, a licensed 503A compounding pharmacy is an accountable entity making the product under sterile standards, and there’s follow-up, which matters most for testosterone given the need to watch for things like atrial fibrillation. The gray market removes that person from the equation on purpose.
Are these peptides banned if I compete in a tested sport? Yes. Under the 2026 WADA Prohibited List, peptide hormones, growth factors, and growth-hormone secretagogues are banned under class S2, covering sermorelin, CJC-1295, and ipamorelin, and testosterone is banned too. A “research use only” label does nothing for you at a drug test. Banned is banned regardless of what the bottle claims.
Does removing BPC-157 from the FDA’s do-not-compound list mean it’s approved now? No, and that distinction matters. BPC-157 came off the FDA’s Category 2 do-not-compound list in April 2026, but removal is not approval. An advisory committee review is scheduled for July 2026 to sort out where it actually belongs. It’s still a compound without an FDA-approved indication and without human clinical safety data.
Are peptides safe for men over 40?
Safety depends almost entirely on which peptide, what dose, and where it comes from. Peptides prescribed through a licensed physician and compounded by a regulated pharmacy carry a very different risk profile than vials ordered from a research-chemical website with no quality testing. Known concerns include injection-site reactions, water retention, changes in cortisol or insulin sensitivity, and, with some growth-hormone secretagogues, potential effects on existing tumors. Age-related health changes common in men over 40, like pre-diabetes or sleep apnea, can make certain peptides riskier without proper screening first.
Do peptides actually work for men, or is it mostly hype?
Some peptides have real, published evidence behind them, and some are mostly forum speculation dressed up as fact. BPC-157 and TB-500, two of the most popular recovery peptides, have interesting animal data but very limited human clinical trials. Growth-hormone secretagogues like sermorelin have more human research and an FDA-approval history for specific deficiencies. The honest answer is that results vary by peptide, and a lot of what circulates online conflates early-stage research with proven outcomes.
What are the best peptides for men trying to maintain muscle and energy after 40?
There’s no single best option, because the right peptide depends on your labs, your symptoms, and your goals, not on which forum thread convinced you. That said, growth-hormone-releasing peptides and sermorelin analogs get the most attention for body composition and energy in middle-aged men, partly because declining GH output is a documented part of aging. Peptides like ipamorelin are often discussed for a relatively cleaner side-effect profile compared to older secretagogues. A physician who actually reviews your IGF-1 levels and medical history is the only person positioned to recommend something specific.
Where can a man over 40 actually buy peptides without getting burned by a sketchy source?
The legitimate route is through a physician’s prescription filled at a licensed compounding pharmacy, which means the product is tested, dosed accurately, and tied to someone medically accountable for your care. Telehealth clinics that specialize in men’s health and compounding pharmacies like FormBlends operate inside that regulated framework. The gray market, meaning research-chemical sites that label products “not for human use” to skirt regulation, offers no quality guarantees and leaves you with no recourse if something goes wrong.
References
- Corpas E, et al. “Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.” J Clin Endocrinol Metab. 1992. https://pubmed.ncbi.nlm.nih.gov/1379256/
- Teichman SL, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Beck DE, et al. “Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.” Int J Colorectal Dis. 2014 (missed primary endpoint, p = 0.15).
- Vasireddi N, et al. “Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.” HSS Journal. 2025 (mostly preclinical; no clinical safety data; no FDA-approved indication).
- Lincoff AM, et al. “Cardiovascular Safety of Testosterone-Replacement Therapy” (TRAVERSE). N Engl J Med. 2023 (n=5,246; noninferior for MACE; more atrial fibrillation).
- Martens CR, et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nat Commun. 2018.
- USADA. “2026 WADA Prohibited List” (S2: peptide hormones, growth factors, and GH secretagogues prohibited in sport).
- Frier Levitt. “FDA Peptide Update 2026: Removal from ‘Do Not Compound’ List and What It Means for Pharmacies” (BPC-157 removed from Category 2 in April 2026; PCAC review July 2026; removal is not approval).
